Evaluated articles

The Effect of COVID-19 Diagnosis on the Physical, Social, and Psychological Well-Being of People in the United Arab Emirates: An Explorative Qualitative Study

1. Mouza AlKuwaiti
2. Bayan Abu Hamada
3. Noof Aljneibi
4. Marília Silva Paulo
5. Iffat Elbarazi

Reviewed by ScreenIT

Mutational Signatures as Sensors of Environmental Exposures: Role of Smoking in COVID-19 Vulnerabilities

1. Yoo-Ah Kim
2. Ermin Hodzic
3. Ariella Saslafsky
4. Damian Wojtowicz
5. Bayarbaatar Amgalan
6. Teresa M. Przytycka

Reviewed by ScreenIT

Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients

1. Maria Paz Ventero
2. Oscar Moreno-Perez
3. Carmen Molina-Pardines
4. Andreu Paytuví-Gallart
5. Vicente Boix
6. Isabel Escribano
7. Irene Galan
8. Pilar González-delaAleja
9. Mario López-Pérez
10. Rosario Sánchez-Martínez
11. Esperanza Merino
12. Juan Carlos Rodríguez

Reviewed by ScreenIT

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

1. Jeffrey Seow
2. Carl Graham
3. Sadie R. Hallett
4. Thomas Lechmere
5. Thomas J.A. Maguire
6. Isabella Huettner
7. Daniel Cox
8. Hataf Khan
9. Suzanne Pickering
10. Rebekah Roberts
11. Anele Waters
12. Christopher C. Ward
13. Christine Mant
14. Michael J. Pitcher
15. Jo Spencer
16. Julie Fox
17. Michael H. Malim
18. Katie J. Doores

Reviewed by ScreenIT

BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype

1. Gisella Guerrera
2. Mario Picozza
3. Silvia D’Orso
4. Roberta Placido
5. Marta Pirronello
6. Alice Verdiani
7. Andrea Termine
8. Carlo Fabrizio
9. Flavia Giannessi
10. Manolo Sambucci
11. Maria Pia Balice
12. Carlo Caltagirone
13. Antonino Salvia
14. Angelo Rossini
15. Luca Battistini
16. Giovanna Borsellino

Reviewed by ScreenIT

Burden of Covid-19 restrictions: National, regional and global estimates

1. Günther Fink
2. Fabrizio Tediosi
3. Stefan Felder

Reviewed by ScreenIT

A standardized instrument quantifying risk factors associated with bi-directional transmission of SARS-CoV-2 and other zoonotic pathogens: The COVID-19 human-animal interactions survey (CHAIS)

1. Jonathon D. Gass
2. Kaitlin B. Waite
3. Nichola J. Hill
4. Kathryn R. Dalton
5. Kaitlin Sawatzki
6. Jonathan A. Runstadler
7. Meghan F. Davis

Reviewed by ScreenIT

Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020–May 2021

1. Alexia Couture
2. B Casey Lyons
3. Megha L Mehrotra
4. Lynn Sosa
5. Ngozi Ezike
6. Farah S Ahmed
7. Catherine M Brown
8. Stephanie Yendell
9. Ihsan A Azzam
10. Božena J Katić
11. Anna Cope
12. Kristen Dickerson
13. Jolianne Stone
14. L Brannon Traxler
15. John R Dunn
16. Lora B Davis
17. Carrie Reed
18. Kristie E N Clarke
19. Brendan Flannery
20. Myrna D Charles

Reviewed by ScreenIT

Analysis of the ARTIC Version 3 and Version 4 SARS-CoV-2 Primers and Their Impact on the Detection of the G142D Amino Acid Substitution in the Spike Protein

1. James J. Davis
2. S. Wesley Long
3. Paul A. Christensen
4. Randall J. Olsen
5. Robert Olson
6. Maulik Shukla
7. Sishir Subedi
8. Rick Stevens
9. James M. Musser

Reviewed by ScreenIT

Induction of robust neutralizing antibodies against the COVID-19 Delta variant with ChAdOx1 nCoV-19 or BNT162b2 as a booster following a primary vaccination series with CoronaVac

1. Samadhi Patamatamkul
2. Sutthiwan Thammawat
3. Benjaporn Buranrat

Reviewed by ScreenIT

SARS-CoV-2 Transmission Potential and Policy Changes in South Carolina, February 2020 – January 2021

1. Margaret R. Davies
2. Xinyi Hua
3. Terrence D. Jacobs
4. Gabi I. Wiggill
5. Po-Ying Lai
6. Zhanwei Du
7. Swati DebRoy
8. Sara Wagner Robb
9. Gerardo Chowell
10. Isaac Chun-Hai Fung

Reviewed by ScreenIT

In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach

1. Michael Maes
2. Walton Luiz Del Tedesco Junior
3. Marcell Alysson Batisti Lozovoy
4. Mayara Tiemi Enokida Mori
5. Tiago Danelli
6. Elaine Regina Delicato de Almeida
7. Alexandre Mestre Tejo
8. Zuleica Naomi Tano
9. Edna Maria Vissoci Reiche
10. Andréa Name Colado Simão

Reviewed by ScreenIT

Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study

1. Michael Ahlers
2. Hilary Aralis
3. Wilson Tang
4. Jeremy B Sussman
5. Gregg C Fonarow
6. Boback Ziaeian

Reviewed by ScreenIT

Large-scale seroepidemiologic surveillance of COVID-19 - Cross-sectional study in Hyogo prefecture of Japan in August, 2021

1. Zhenxiao Ren
2. Koichi Furukawa
3. Mitsuhiro Nishimura
4. Yukiya Kurahashi
5. Silvia Sutandhio
6. Lidya Handayani Tjan
7. Kaito Aoki
8. Natsumi Hasegawa
9. Jun Arii
10. Kenichi Uto
11. Keiji Matsui
12. Itsuko Sato
13. Jun Saegusa
14. Nonoka Godai
15. Kohei Takeshita
16. Masaki Yamamoto
17. Tatsuya Nagashima
18. Yasuko Mori

Reviewed by ScreenIT

Milk casein prevents inactivation effect of black tea galloylated theaflavins on SARS-CoV-2 in vitro

1. Eriko Ohgitani
2. Masaharu Shin-Ya
3. Masaki Ichitani
4. Makoto Kobayashi
5. Takanobu Takihara
6. Motoki Saito
7. Hitoshi Kinugasa
8. Osam Mazda

Reviewed by ScreenIT

Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia

1. Andrea L. Schaffer
2. David Henry
3. Helga Zoega
4. Julian H. Elliott
5. Sallie-Anne Pearson

Reviewed by ScreenIT

Modeling of COVID-19 Transmission Dynamics on US Population: Inter-transfer Infection in Age Groups, Mutant Variants and Vaccination Strategies

1. Jyotirmoy Roy
2. Samuel Heath
3. Doraiswami Ramkrishna
4. Shiyan Wang

Reviewed by ScreenIT

5. Laboratory AGEIS EA 7407, Team Tools for e-Gnosis Medical & Labcom CNRS/UGA/OrangeLabs Telecom4Health, Faculty of Medicine, University Grenoble Alpes (UGA), 38700 La Tronche, France

Reviewed by ScreenIT

Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study

1. Marit J. van Gils
2. Ayesha Lavell
3. Karlijn van der Straten
4. Brent Appelman
5. Ilja Bontjer
6. Meliawati Poniman
7. Judith A. Burger
8. Melissa Oomen
9. Joey H. Bouhuijs
10. Lonneke A. van Vught
11. Marleen A. Slim
12. Michiel Schinkel
13. Elke Wynberg
14. Hugo D. G. van Willigen
15. Marloes Grobben
16. Khadija Tejjani
17. Jacqueline van Rijswijk
18. Jonne L. Snitselaar
19. Tom G. Caniels
20. Amsterdam UMC COVID-19 S3/HCW study group
21. Alexander P. J. Vlaar
22. Maria Prins
23. Menno D. de Jong
24. Godelieve J. de Bree
25. Jonne J. Sikkens
26. Marije K. Bomers
27. Rogier W. Sanders

Reviewed by ScreenIT

Effectivenessof the mRNA BNT162b2 vaccine against SARS-CoV-2 severeinfections in the Israeli over 60 population: a temporal analysis done byusing the national surveillance data.

1. Department of AppliedMathematics, Campinas StateUniversity, Brazil
2. Stefano De Leo

Reviewed by ScreenIT